Litcius/Paper detail

Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review

Edith A. Perez, Chau T. Dang, Caleb Lee, Jasmeet Singh, Kongming Wang, J. Bradley Layton, Alicia Gilsenan, Michelle D. Hackshaw, Javier Cortés

2022Breast Cancer Research and Treatment20 citationsDOI

Topics & Concepts

MedicineLapatinibTrastuzumabInternal medicinePertuzumabOncologyNeratinibAdverse effectMetastatic breast cancerBreast cancerCancerHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyAdvanced Breast Cancer Therapies
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review | Litcius